Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

380 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characterization of tumor-infiltrating lymphocyte subsets from human renal cell carcinoma: specific reactivity defined by cytotoxicity, interferon-gamma secretion, and proliferation.
Finke JH, Rayman P, Hart L, Alexander JP, Edinger MG, Tubbs RR, Klein E, Tuason L, Bukowski RM. Finke JH, et al. Among authors: bukowski rm. J Immunother Emphasis Tumor Immunol. 1994 Feb;15(2):91-104. doi: 10.1097/00002371-199402000-00002. J Immunother Emphasis Tumor Immunol. 1994. PMID: 7907918
Phase I study of WR-2721 and carboplatin.
Budd GT, Ganapathi R, Bauer L, Murthy S, Adelstein D, Weick J, Gibson V, McLain D, Sergi J, Bukowski RM. Budd GT, et al. Among authors: bukowski rm. Eur J Cancer. 1993;29A(8):1122-7. doi: 10.1016/s0959-8049(05)80301-6. Eur J Cancer. 1993. PMID: 8390844 Clinical Trial.
Immunomodulatory effects of interleukin-2 and interleukin-4 in patients with malignancy.
Olencki T, Finke J, Tubbs R, Tuason L, Greene T, McLain D, Swanson SJ, Herzog P, Stanley J, Edinger M, Budd GT, Bukowski RM. Olencki T, et al. Among authors: bukowski rm. J Immunother Emphasis Tumor Immunol. 1996 Jan;19(1):69-80. doi: 10.1097/00002371-199601000-00008. J Immunother Emphasis Tumor Immunol. 1996. PMID: 8859726 Clinical Trial.
380 results